17:11 IST
BSE
Board Meeting Outcome
Beryl Drugs Board Meeting Outcome
Beryl Drugs Limited approved items for its 33rd Annual General Meeting and a proposal to increase material related party transaction limits.
Beryl Drugs Ltd
- Share price
- ₹25.55
- Market cap
- ₹12.96 Cr
- Revenue (annual)
- ₹18.82 Cr
- Net profit (annual)
- ₹0.42 Cr
- P/E (TTM)
- 20.8×Sector 47.3×
- Promoter holding
- 27.82%+0.34% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Board Meeting Outcome 2Board Meeting Date 2Promoter Buying 1Financial Results 1Annual Report 1Annual General Meeting 1Adverse Business Impact 1
Time
2 announcements with these filters
17:06 IST
BSE
Board Meeting Outcome
Beryl Drugs Board Meeting Outcome
Beryl Drugs Ltd's board meeting on August 11, 2026, approved the unaudited financial results for the quarter ended June 30, 2026.